Methylphenidate modulates brain-circuit connectivity in cocaine-addicted individuals

June 27, 2013
Methylphenidate differentially changes the strength of connectivity, or crosstalk, between brain areas shown to play a role in addiction. Scans collected in cocaine addicted subjects during placebo effects revealed strong connectivity between the brain's reward center and areas involved in forming habits (top row, left) and weak connectivity between higher-order brain areas involved in regulating emotions and self-control (bottom row, left). However, when subjects were given a dose of methylphenidate, a drug that increases dopamine in the brain, the strength of these connections was normalized (right).

(Medical Xpress)—Several brain-imaging studies have revealed disruptions in communication between brain regions in people addicted to cocaine. A new study conducted at the U.S. Department of Energy's Brookhaven National Laboratory shows that a single oral dose of methylphenidate, a drug commonly used to treat attention deficit hyperactivity disorder (ADHD), modifies connectivity in particular disrupted brain circuits in ways that could potentially help improve self-control and reduce craving among cocaine-addicted individuals. The research is published in JAMA Psychiatry as an Online First Publication, June 26, 2013.

"This study shows promising short-term effects, and suggests the importance of conducting further studies to determine whether methylphenidate could be used as part of a treatment strategy for ," said Anna Konova, a Stony Brook University doctoral student in Brookhaven's Biosciences Department and the study's lead author.

Earlier research* has shown that oral methylphenidate improved brain function in performing specific cognitive tasks. It is likely that those effects were related to methylphenidate's blockade of nerve cell proteins that clear dopamine, an important brain-cell communication chemical. By extending dopamine's action, the drug enhances signaling to improve several functions (including attention and processing of salient information) in people with impaired dopamine function, such as chronic drug users or people suffering from ADHD.

The new study was designed to test the effects of methylphenidate (vs. a placebo) on the strength of connectivity, or crosstalk, between specific previously shown to play a role in addiction—for example, the reward center and areas involved in forming habits, memories, and exerting self-control.

The scientists—from Brookhaven, Stony Brook, and the National Institutes of Health—used functional (fMRI) to measure the strength of connectivity in particular before and after subjects were given either a 20-milligram oral dose of methylphenidate or a placebo. They also assessed each subject's severity of addiction to see if this had any bearing on the results.

The scans showed that methylphenidate strengthened connectivity between several brain regions involved in regulating emotions and exerting control over behaviors—connections previously reported to be disrupted in cocaine addiction. Methylphenidate also decreased connectivity between areas of the brain that have been strongly implicated in the formation of habits, including compulsive drug seeking and craving.

Furthermore, comparison of cocaine users to healthy subjects showed that differences in connectivity in some brain regions were related to subjects' severity of addiction before methylphenidate administration. In tests performed after the drug was given, these differences were no longer significant, suggesting that methylphenidate could, at least transiently, change abnormal connectivity between these regions.

"These changes in connectivity strength are consistent with a beneficial response to methylphenidate, extending its previously reported efficacy in normalizing task-related brain function and behavior in people addicted to cocaine," Konova said. "By giving subjects methylphenidate, we are manipulating the level of dopamine, which is improving connectivity among key brain regions relevant to addiction."

Although these results were visible after a single dose, they may be clinically relevant and merit further study, the researchers say, to evaluate the potential use of methylphenidate as part of an addiction-treatment strategy. "For example, these future studies could test if adjunct treatment with methylphenidate can enhance the effectiveness of cognitive-based therapies for cocaine addiction that are targeted toward increasing emotion regulation and self-control and decreasing conditioned associations," Konova said.

The paper is titled "Effects of Methylphenidate on Resting-State Functional Connectivity of the Mesocorticolimbic Dopamine Pathways in Cocaine Addiction."

Explore further: Long-term ADHD treatment increases brain dopamine transporter levels, may affect drug efficacy

More information: archpsyc.jamanetwork.com/journal.aspx

Related Stories

Long-term ADHD treatment increases brain dopamine transporter levels, may affect drug efficacy

May 15, 2013
Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published May 15 in the open access journal ...

Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD

May 9, 2013
The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry.

Mental fatigue impairs midbrain function in cocaine-addicted individuals, researchers find

November 9, 2012
(Medical Xpress)—Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have revealed a new connection between drug addiction and a distinct part of the brain that may govern motivation. The ...

Animal study: long-term ritalin doesn't impact growth

July 20, 2012
(HealthDay) -- Chronic use of methylphenidate (Ritalin) in young monkeys has no significant effect on growth or the dopamine system, or the likelihood of becoming addicted to cocaine, according to a study published online ...

Recommended for you

Study finds gene variant increases risk for depression

July 20, 2017
A University of Central Florida study has found that a gene variant, thought to be carried by nearly 25 percent of the population, increases the odds of developing depression.

Study examines effects of stopping psychiatric medication

July 20, 2017
Despite numerous obstacles and severe withdrawal effects, long-term users of psychiatric drugs can stop taking them if they choose, and mental health care professionals could be more helpful to such individuals, according ...

In making decisions, are you an ant or a grasshopper?

July 20, 2017
In one of Aesop's famous fables, we are introduced to the grasshopper and the ant, whose decisions about how to spend their time affect their lives and future. The jovial grasshopper has a blast all summer singing and playing, ...

Perceiving oneself as less physically active than peers is linked to a shorter lifespan

July 20, 2017
Would you say that you are physically more active, less active, or about equally active as other people your age?

New study suggests that reduced insurance coverage for mental health treatment increases costs for the seriously ill

July 19, 2017
Higher out-of-pocket costs for mental health care could have the unintended consequence of increasing the use of acute and involuntary mental health care among those suffering from the most debilitating disorders, a Harvard ...

Old antibiotic could form new depression treatment

July 19, 2017
An antibiotic used mostly to treat acne has been found to improve the quality of life for people with major depression, in a world-first clinical trial conducted at Deakin University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.